mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.3 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.3 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
0.18 |
0.3 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |